Publications in collaboration with researchers from Universidade da Coruña (26)

2019

  1. Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept

    PLoS ONE, Vol. 14, Núm. 2

  2. Objectives and methodology of BIOBADASER phase III

    Reumatologia Clinica, Vol. 15, Núm. 4, pp. 229-236

2018

  1. Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis

    PLoS ONE, Vol. 13, Núm. 5

2016

  1. Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis

    Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140

  2. Specific premature epigenetic aging of cartilage in osteoarthritis

    Aging, Vol. 8, Núm. 9, pp. 2222-2231

2015

  1. Basic Aspects of Adipokines in Bone Metabolism

    Clinical Reviews in Bone and Mineral Metabolism, Vol. 13, Núm. 1, pp. 11-19

  2. Choosing the right chondrocyte cell line: Focus on nitric oxide

    Journal of Orthopaedic Research, Vol. 33, Núm. 12, pp. 1784-1788

  3. IL-36α: A novel cytokine involved in the catabolic and inflammatory response in chondrocytes

    Scientific Reports, Vol. 5

  4. Identification of novel adipokines in the joint.Differential expression in healthy and osteoarthritis tissues

    PLoS ONE, Vol. 10, Núm. 4

  5. New drugs from ancient natural foods. Oleocanthal, the natural occurring spicy compound of olive oil: A brief history

    Drug Discovery Today

  6. Non-dioxin-like polychlorinated biphenyls (PCB 101, PCB 153 and PCB 180) induce chondrocyte cell death through multiple pathways

    Toxicology Letters, Vol. 234, Núm. 1, pp. 13-19

  7. Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: A case-only study

    Arthritis Research and Therapy, Vol. 17, Núm. 1

  8. SERPINE2 inhibits IL-1α-induced MMP-13 expression in human chondrocytes: Involvement of ERK/NF-κB/AP-1 pathways

    PLoS ONE, Vol. 10, Núm. 8

  9. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases

    Biomarkers, Vol. 20, Núm. 8, pp. 565-571

2014

  1. Adipokines, metabolic syndrome and rheumatic diseases

    Journal of Immunology Research, Vol. 2014

  2. An update on leptin as immunomodulator

    Expert Review of Clinical Immunology, Vol. 10, Núm. 9, pp. 1165-1170

  3. Bone metabolism and adipokines: Are there perspectives for bone diseases drug discovery?

    Expert Opinion on Drug Discovery, Vol. 9, Núm. 8, pp. 945-957

  4. Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals

    Annals of the Rheumatic Diseases

  5. Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 16, Núm. 3

  6. Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: Case-control study

    Arthritis Research and Therapy, Vol. 16, Núm. 1